CoChat

Management of Severe Insulin Resistance in Patients with Type 1 Diabetes

Schechter, Rebecca, Reutrakul, Sirimon · 2015 · Current Diabetes Reports

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Abstract

Managing severe insulin resistance (IR) in patients with type 1 diabetes (T1DM) can be challenging for both clinicians and patients. As average weight for patients with T1DM has increased in recent decades, IR in this population has become more widespread. Currently, almost 50 % of patients with T1DM are overweight or obese. While intensive insulin therapy is associated with reduction in complications, aggressive treatment can lead to weight gain. With increasing weight, insulin can become less effective to control glycemia, resulting in higher insulin doses and hence more weight gain. Novel strategies to break this vicious cycle are needed. This review will investigate current research on insulin formulations, lifestyle modification, adjunct therapies, and surgery that may help better manage patients with T1DM and IR.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11892-015-0641-2

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 103 references

Research works printed but not linked: 3

  1. Garg R, Lawrence IG, Akinsola MO, Davies MJ, McNally PG. Improved glycaemic control in severely insulin resistant, insulin treated diabetic patients with U500 human actrapid over 2 years follow-up. Diabetologia. 2004;47 Suppl 1:A58.
  2. Nayyar V, Lawrence IG, Kong MF, Gallagher A, Gregory R, Hiles S, et al. Long-term follow-up of patietns on U-500 human actrapid. Diabetologia. 2007;50(Suppl1):S538.
  3. Matsuhisa M, Koyama M, Cheng X, Shimizu S, Hirose T, EDITION JP1 Study Group. New insulin glargine 300 U/mL: glycemic control and hypoglycemia in Japanese people with T1DM (edition JP 1). Diabetes. 2014;63 Suppl 1:LB22. An open-label study compared Gla-300 vs. Gal-100 in 243 Japanese patients with T1DM for 6 months. Both insulins resulted in similar HbA1c reduction, with less confirmed or severe nocturnal hypoglycemic events with Gla-300, particularly in the first 8 weeks.

Cited by

See all 15

Metadata

Authors
Schechter, R., & Reutrakul, S.
Affiliations
Mahidol University (TH)
Corresponding author
Reutrakul, Sirimon
Venue
Current Diabetes Reports
Published
2015-08-21
Volume
15
Issue
10
Pages
77-77
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
OpenAlex
W1143305783
Cited by
15
References
102
Citations by year
2025: 2 · 2023: 1 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 2
FWCI
0.30
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Diabetes Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
insulin resistance, type 1 diabetes, obesity, weight gain, intensive insulin therapy, insulin formulations, lifestyle modification, adjunctive therapy, bariatric surgery, glycemic control
MeSH terms
Diabetes Mellitus, Type 1, Diet, Diet Therapy, Exercise Therapy, Humans, Insulin, Insulin Resistance, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Severe Insulin Resistance in Patients with Type 1 Diabetes. https://app.cochat.ai/papers/10.1007/s11892-015-0641-2
The paper
Schechter, R., & Reutrakul, S. (2015). Management of Severe Insulin Resistance in Patients with Type 1 Diabetes. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0641-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.